Skip to content

Clinical trials

Lung Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Italy Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20062
20081
20091
20101
20113
20124
20131
20142
20152
20164
20176
20181
20196
20203
20212
20223
20236
20247
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting15
Active, not recruiting7
Terminated6
Unknown status4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Eli Lilly and Company4
Bayer3
Novartis Pharmaceuticals3
Revolution Medicines, Inc.3
United Therapeutics3
European Institute of Oncology2
Hoffmann-La Roche2
Istituti Clinici Scientifici Maugeri SpA2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases65
Respiratory Tract Diseases25
Lung Neoplasms20
Carcinoma, Non-Small-Cell Lung17
Neoplasms14
Respiratory Tract Neoplasms12
Thoracic Neoplasms12
Bronchial Neoplasms11
Pulmonary Disease, Chronic Obstructive11
Neoplasms by Site10

Trials

Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.